Non Hodgkin Lymphoma Clinical Trial

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Summary

This study will provide long-term follow-up for patients who have received treatment with a Juno CAR T-cell product in a Juno-sponsored clinical trial. In this study, patients will be followed for up to 15 years after their last dose of Juno CAR T cells for evaluation of delayed adverse events, presence of persisting CAR T-cell vector sequences, presence of replication-competent retrovirus (RCR) or lentivirus (RCL), and survival.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who have received at least one dose of a Juno CAR T-cell product (listed above) in a Juno-sponsored clinical trial
Patients who have provided informed consent for the long-term follow-up study

Exclusion Criteria:

None. All patients who have previously received treatment with a Juno CAR T-cell product are eligible for this long-term follow-up study.

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

4

Study ID:

NCT03436771

Recruitment Status:

Terminated

Sponsor:

Juno Therapeutics, a Subsidiary of Celgene

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

City of Hope
Duarte California, 91010, United States
Massachusetts General Hospital
Boston Massachusetts, 02114, United States

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

4

Study ID:

NCT03436771

Recruitment Status:

Terminated

Sponsor:


Juno Therapeutics, a Subsidiary of Celgene

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider